602 related articles for article (PubMed ID: 30125562)
1. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
Biswas S; Rao CM
Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
3. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
Simó-Riudalbas L; Esteller M
Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
[TBL] [Abstract][Full Text] [Related]
4. Development and classes of epigenetic drugs for cancer.
Dhanak D; Jackson P
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
[TBL] [Abstract][Full Text] [Related]
5. Targeting Epigenetics in Cancer.
Bennett RL; Licht JD
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
[TBL] [Abstract][Full Text] [Related]
6. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Priming and Development of New Combination Therapy Approaches.
Meneceur S; Grunewald CM; Niegisch G; Hoffmann MJ
Methods Mol Biol; 2023; 2684():259-281. PubMed ID: 37410240
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Modulators as Therapeutic Agents in Cancer.
Patnaik E; Madu C; Lu Y
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834411
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery.
Ganesan A; Nolan L; Crabb SJ; Packham G
Curr Cancer Drug Targets; 2009 Dec; 9(8):963-81. PubMed ID: 20025605
[TBL] [Abstract][Full Text] [Related]
13. Role of epigenome in tumorigenesis and drug resistance.
Hu Q; Baeg GH
Food Chem Toxicol; 2017 Nov; 109(Pt 1):663-668. PubMed ID: 28709969
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathways: the complexity of the epigenome in cancer and recent clinical advances.
Conte M; Altucci L
Clin Cancer Res; 2012 Oct; 18(20):5526-34. PubMed ID: 22904103
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
16. Current Status of Epigenetics and Anticancer Drug Discovery.
Jin P; Chen X
Anticancer Agents Med Chem; 2016; 16(6):699-712. PubMed ID: 26567620
[TBL] [Abstract][Full Text] [Related]
17. Targeting epigenetic regulation for cancer therapy using small molecule inhibitors.
Kumar A; Emdad L; Fisher PB; Das SK
Adv Cancer Res; 2023; 158():73-161. PubMed ID: 36990539
[TBL] [Abstract][Full Text] [Related]
18. Histone modification therapy of cancer.
Biancotto C; Frigè G; Minucci S
Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
[TBL] [Abstract][Full Text] [Related]
19. Functional coupling between writers, erasers and readers of histone and DNA methylation.
Torres IO; Fujimori DG
Curr Opin Struct Biol; 2015 Dec; 35():68-75. PubMed ID: 26496625
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the interplay of histone post-translational modifications in cancer: Co-targeting histone modulators for precision therapy.
Kawaf RR; Ramadan WS; El-Awady R
Life Sci; 2024 Jun; 346():122639. PubMed ID: 38615747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
